435 related articles for article (PubMed ID: 16875702)
1. Inhibition of phosphodiesterase activity, airway inflammation and hyperresponsiveness by PDE4 inhibitor and glucocorticoid in a murine model of allergic asthma.
Sun JG; Deng YM; Wu X; Tang HF; Deng JF; Chen JQ; Yang SY; Xie QM
Life Sci; 2006 Oct; 79(22):2077-85. PubMed ID: 16875702
[TBL] [Abstract][Full Text] [Related]
2. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
[TBL] [Abstract][Full Text] [Related]
3. Action of a Novel PDE4 inhibitor ZL-n-91 on lipopolysaccharide-induced acute lung injury.
Tang HF; Lu JJ; Tang JF; Zheng X; Liang YQ; Wang XF; Wang YJ; Mao LG; Chen JQ
Int Immunopharmacol; 2010 Apr; 10(4):406-11. PubMed ID: 20074667
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of acetamide-45 on airway inflammation and phosphodiesterase 4 in allergic rats.
Wang K; Shen HH; Chen JC; Chen Z
Acta Pharmacol Sin; 2005 Dec; 26(12):1492-6. PubMed ID: 16297349
[TBL] [Abstract][Full Text] [Related]
5. In vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor.
Foissier L; Lonchampt M; Cogé F; Canet E
J Pharmacol Exp Ther; 1996 Sep; 278(3):1484-90. PubMed ID: 8819536
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
7. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor.
Bundschuh DS; Eltze M; Barsig J; Wollin L; Hatzelmann A; Beume R
J Pharmacol Exp Ther; 2001 Apr; 297(1):280-90. PubMed ID: 11259555
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of airway inflammation, hyperresponsiveness and remodeling by soy isoflavone in a murine model of allergic asthma.
Bao ZS; Hong L; Guan Y; Dong XW; Zheng HS; Tan GL; Xie QM
Int Immunopharmacol; 2011 Aug; 11(8):899-906. PubMed ID: 21354484
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors.
Wollin L; Bundschuh DS; Wohlsen A; Marx D; Beume R
Pulm Pharmacol Ther; 2006; 19(5):343-52. PubMed ID: 16257550
[TBL] [Abstract][Full Text] [Related]
10. Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma.
Herbert C; Hettiaratchi A; Webb DC; Thomas PS; Foster PS; Kumar RK
Clin Exp Allergy; 2008 May; 38(5):847-56. PubMed ID: 18307529
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma.
Kumar RK; Herbert C; Thomas PS; Wollin L; Beume R; Yang M; Webb DC; Foster PS
J Pharmacol Exp Ther; 2003 Oct; 307(1):349-55. PubMed ID: 12954795
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479
[TBL] [Abstract][Full Text] [Related]
13. The effects of increased cAMP content on inflammation, oxidative stress and PDE4 transcripts during Brucella melitensis infection.
Erdogan S; Aslantas O; Celik S; Atik E
Res Vet Sci; 2008 Feb; 84(1):18-25. PubMed ID: 17397885
[TBL] [Abstract][Full Text] [Related]
14. Piperine inhibits eosinophil infiltration and airway hyperresponsiveness by suppressing T cell activity and Th2 cytokine production in the ovalbumin-induced asthma model.
Kim SH; Lee YC
J Pharm Pharmacol; 2009 Mar; 61(3):353-9. PubMed ID: 19222908
[TBL] [Abstract][Full Text] [Related]
15. Acetamide-45 inhibited hyperresponsiveness and airway inflammation in mice partly depending on phosphodiesterase activity suppression.
Wang K; Shen HH; Huang HQ; Chen JC; Chen Z
Acta Pharmacol Sin; 2008 Oct; 29(10):1195-201. PubMed ID: 18817624
[TBL] [Abstract][Full Text] [Related]
16. Effect of adrenaline and glucocorticoids on monocyte cAMP-specific phosphodiesterase (PDE4) in a monocytic cell line.
Delgado M; Fernández-Alfonso MS; Fuentes A
Arch Dermatol Res; 2002 Jul; 294(4):190-7. PubMed ID: 12111350
[TBL] [Abstract][Full Text] [Related]
17. Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats.
Chapman RW; House A; Jones H; Richard J; Celly C; Prelusky D; Ting P; Hunter JC; Lamca J; Phillips JE
Eur J Pharmacol; 2007 Oct; 571(2-3):215-21. PubMed ID: 17610865
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase type 4 inhibitors cause proinflammatory effects in vivo.
McCluskie K; Klein U; Linnevers C; Ji YH; Yang A; Husfeld C; Thomas GR
J Pharmacol Exp Ther; 2006 Oct; 319(1):468-76. PubMed ID: 16861399
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of phosphodiesterase-4 in the lung of allergic rats.
Tang HF; Song YH; Chen JC; Chen JQ; Wang P
Am J Respir Crit Care Med; 2005 Apr; 171(8):823-8. PubMed ID: 15665325
[TBL] [Abstract][Full Text] [Related]
20. Effects of phosphodiesterase 4 inhibitor on cough response in guinea pigs sensitized and challenged with ovalbumin.
Lü HJ; Qiu ZM; Wei WL; Yu L; Liu RL; Zhang M
Chin Med J (Engl); 2004 Nov; 117(11):1620-4. PubMed ID: 15569475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
